Transfection News and Research

RSS
Covaris launches Bench-top SF220 Formulation Processing System

Covaris launches Bench-top SF220 Formulation Processing System

PET imaging may play a role in early evaluation of vandetanib response in thyroid cancer

PET imaging may play a role in early evaluation of vandetanib response in thyroid cancer

Novel AAV gene therapy offers various advantages

Novel AAV gene therapy offers various advantages

Nacalai to distribute Techulon's Glycofect Transfection Reagent platform products in Japan

Nacalai to distribute Techulon's Glycofect Transfection Reagent platform products in Japan

Roche introduces X-tremeGENE 9, X-tremeGENE HP reagents

Roche introduces X-tremeGENE 9, X-tremeGENE HP reagents

Life Technologies launches Qubit 2.0 Fluorometer for molecular biology research

Life Technologies launches Qubit 2.0 Fluorometer for molecular biology research

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Altogen Biosystems releases PEG-Liposome siRNA In Vivo Transfection Kit

Altogen Biosystems releases PEG-Liposome siRNA In Vivo Transfection Kit

Study demonstrates potential of nontoxic envelope proteins as an alternative to pseudotype lentiviral vectors

Study demonstrates potential of nontoxic envelope proteins as an alternative to pseudotype lentiviral vectors

Access Pharmaceuticals reports significant progress in Cobalamin-targeted drug-delivery program for siRNA therapies

Access Pharmaceuticals reports significant progress in Cobalamin-targeted drug-delivery program for siRNA therapies

FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer

FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer

Promega to provide FuGENE HD Transfection Reagent throughout life science market

Promega to provide FuGENE HD Transfection Reagent throughout life science market

Mirus Bio launches new TransIT-PRO transfection kit for biotherapeutic protein production

Mirus Bio launches new TransIT-PRO transfection kit for biotherapeutic protein production

Life Technologies, CEVEC Pharmaceuticals sign licensing agreement to supply CAP-T expression kits

Life Technologies, CEVEC Pharmaceuticals sign licensing agreement to supply CAP-T expression kits

Clontech Laboratories, TET Systems expand license agreement

Clontech Laboratories, TET Systems expand license agreement

Gene therapy holds promise in treating cancer, cardiovascular and neurodegenerative diseases

Gene therapy holds promise in treating cancer, cardiovascular and neurodegenerative diseases

Vandetanib extends Progression Free Survival in ZETA phase III study for advanced medullary thyroid cancer

Vandetanib extends Progression Free Survival in ZETA phase III study for advanced medullary thyroid cancer

MaxCyte STX Scalable Transfection System acquired by CCS Cell Culture Service

MaxCyte STX Scalable Transfection System acquired by CCS Cell Culture Service

Goodwin Biotechnology, Hyprocell sign collaborative agreement to strengthen clinical development services

Goodwin Biotechnology, Hyprocell sign collaborative agreement to strengthen clinical development services